Analysis of serum adenosine deaminase (ADA) and ADA1 and ADA2 isoenzyme activities in HIV positive and HIV–HBV co-infected patients

To determine adenosine deaminase (ADA) activity as a possible diagnostic marker in HIV and HIV–HBV co-infected patients. Blood samples were collected from 72 healthy, 33 HIV positive and 30 HIV–HBV co-infected subjects. Blood CD4+ cell count was recorded and serum alanine aminotransferase, aspartate...

Full description

Saved in:
Bibliographic Details
Published inClinical biochemistry Vol. 44; no. 12; pp. 980 - 983
Main Authors Khodadadi, Iraj, Abdi, Mohammad, Ahmadi, Abbas, Wahedi, Mohammad Saleh, Menbari, Shahoo, Lahoorpour, Fariba, Rahbari, Rezgar
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Inc 01.08.2011
Elsevier
Subjects
Online AccessGet full text
ISSN0009-9120
1873-2933
1873-2933
DOI10.1016/j.clinbiochem.2011.05.020

Cover

More Information
Summary:To determine adenosine deaminase (ADA) activity as a possible diagnostic marker in HIV and HIV–HBV co-infected patients. Blood samples were collected from 72 healthy, 33 HIV positive and 30 HIV–HBV co-infected subjects. Blood CD4+ cell count was recorded and serum alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total ADA, and ADA1 and ADA2 isoenzyme activities were determined. Serum ALT, AST, total ADA and ADA2 isoenzyme activities were significantly higher in HIV positive and HIV–HBV co-infected groups compare to the control ( p < 0.05), whereas serum ALP showed no differences between groups. CD4+ cell counts markedly decreased in all patients and showed a significant inverse correlation with ADA activities (R 2 = 0.589, p < 0.001). Serum ADA was significantly increased in HIV and HIV–HBV co-infections. Therefore, because of its low cost and simplicity to perform, ADA activity might be considered as a useful diagnostic tool among the other markers in these diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0009-9120
1873-2933
1873-2933
DOI:10.1016/j.clinbiochem.2011.05.020